Answers are grounded in this paper and cite their sources.
Explores Fe-Cur nanozymes for reducing inflammation in acute lung injury, highlighting potential therapies.
T cells in mice, which could help suppress the inflammation cytokine storm caused by ALI. Overall, this work has developed the strategy of using Fe-Cur NPs as nanozymes to scavenge intracellular ROS and as an anti-inflammation nanodrugs to synergistically cure ALI, which may serve as a promising therapeutic agent in the clinical treatment of this deadly disease. Fe-Cur NP nanozymes were designed to attenuate ALI by clearing intracellular ROS and alleviating inflammation synergistically. Relevant cytokines, inflammasomes, and signaling pathways were studied.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: